Is Vera Therapeutics, Inc. (VERA) a Buy, Sell, or Hold?
Vera Therapeutics, Inc.
NASDAQ:VERA
$43.13 USD
$1.63 (3.93%)
- Volume
- 2.59M
- Average Volume
- 1.54M
- Market Capitalization
- $3.1B
- P/E Ratio
- -7.79
- Dividend Yield
- 0.00%
- Price Target
- $90.00
- Year High
- $56.05
- Year Low
- $19.07
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.64
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-52.1% DOWNSIDE
$90.00 Price Target
UPSIDE/DOWNSIDE HIGH
-65.5% DOWNSIDE
$125.00 Price Target High
UPSIDE/DOWNSIDE LOW
0.3% UPSIDE
$43.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Guggenheim | Vamil Divan | $76 | $42.96 | 2026-07-08 06:50 AM | 76.9% |
| Jefferies | Farzin Haque | $60 | $31.26 | 2026-06-02 03:56 PM | 91.9% |
| Goldman Sachs | Paul Choi | $90 | $32.135 | 2026-06-02 11:15 AM | 180.1% |
| Wedbush | Laura Chico | $33 | $45.4169 | 2025-12-11 08:21 AM | -27.3% |
| Evercore ISI | Gavin Clark-Gartner | $97 | $45.785 | 2025-12-08 08:34 AM | 111.9% |